Our Guidelines Rundown Series continues with a new article dedicated to Sarcoma Awareness Month. Presently, there exists only a limited number of guidelines pertaining to Soft Tissue Sarcoma (STS), as they have only been released by a few medical societies. These guidelines offer recommendations on the management, treatment, and indications for radiation therapy for STS. Let’s now explore the list of clinical practice guidelines on soft tissue sarcoma:

Guideline From National Comprehensive Cancer Network (NCCN)

  • Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
    • Publication: July 2022
    • Objective: The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for STS address the management of STS in adult patients from the perspective of the following disease subtypes:
      • STS of extremity, superficial/trunk, or head and neck
      • Retroperitoneal or intra-abdominal STS
      • Desmoid tumors (aggressive fibromatoses)
      • Rhabdomyosarcoma

Guideline From American Society for Radiation Oncology (ASTRO)

  • Radiation Therapy for Treatment of Soft Tissue Sarcoma in Adults
    • Publication: July 2021
    • Objective: This guideline provides evidence-based recommendations addressing the indications for radiation therapy (RT), sequencing of local therapies, and appropriate dose and planning techniques for management of primary, operable, localized, soft tissue sarcoma (STS) in adults.

Guideline From Outside the United States

Guideline From European Society for Medical Oncology (ESMO) Guidelines Committee, EURACAN and GENTURIS

Thank you for reviewing the current STS guidelines. If there are any that we may have overlooked, please do not hesitate to inform us. Additionally, we welcome suggestions for future topics to cover in our Guidelines Rundown Series. Sign up for alerts and stay informed on the latest published guidelines and articles. Stay tuned for our next installment!

Copyright © 2024 Guideline Central, All rights reserved.